These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 24172268)

  • 1. Actually delivered dose of continuous renal replacement therapy is underestimated in hemofiltration.
    Zhang Z; Ni H; Fan H; Li D; Xu X
    ASAIO J; 2013; 59(6):622-6. PubMed ID: 24172268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predilution versus postdilution continuous venovenous hemofiltration: no effect on filter life and azotemic control in critically ill patients on heparin.
    Nurmohamed SA; Jallah BP; Vervloet MG; Beishuizen A; Groeneveld AB
    ASAIO J; 2011; 57(1):48-52. PubMed ID: 21084966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of solute clearance in three modes of continuous renal replacement therapy.
    Parakininkas D; Greenbaum LA
    Pediatr Crit Care Med; 2004 May; 5(3):269-74. PubMed ID: 15115566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V; Garg U; Warady BA; Alon US
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal replacement therapy for acute kidney injury in Australian and New Zealand intensive care units: a practice survey.
    RENAL Study Investigators
    Crit Care Resusc; 2008 Sep; 10(3):225-30. PubMed ID: 18798721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effects of dialysate and ultrafiltration flow rate on solute clearance during continuous renal replacement therapy].
    Gong D; Ji D; Xie H; Xu B; Liu Y; Li L
    Zhonghua Nei Ke Za Zhi; 2001 Mar; 40(3):183-6. PubMed ID: 11798577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solutes removal characteristics at various effluent rates during different continuous renal replacement therapy modalities.
    Yu W; Zhuang F; Ma S; Zhu M; Ding F
    Int J Artif Organs; 2019 Jul; 42(7):354-361. PubMed ID: 30905252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated venovenous hemofiltration: early technical and clinical experience.
    Gashti CN; Salcedo S; Robinson V; Rodby RA
    Am J Kidney Dis; 2008 May; 51(5):804-10. PubMed ID: 18436091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
    Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
    Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effluent volume in continuous renal replacement therapy overestimates the delivered dose of dialysis.
    Claure-Del Granado R; Macedo E; Chertow GM; Soroko S; Himmelfarb J; Ikizler TA; Paganini EP; Mehta RL
    Clin J Am Soc Nephrol; 2011 Mar; 6(3):467-75. PubMed ID: 21115626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosing patterns for continuous renal replacement therapy at a large academic medical center in the United States.
    Venkataraman R; Kellum JA; Palevsky P
    J Crit Care; 2002 Dec; 17(4):246-50. PubMed ID: 12501152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variables associated with circuit life span in critically ill patients undergoing continuous renal replacement therapy: a prospective observational study.
    Zhang Z; Ni H; Lu B
    ASAIO J; 2012; 58(1):46-50. PubMed ID: 22210650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solute clearance in CRRT: prescribed dose versus actual delivered dose.
    Lyndon WD; Wille KM; Tolwani AJ
    Nephrol Dial Transplant; 2012 Mar; 27(3):952-6. PubMed ID: 21896498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous renal replacement therapy in critically ill patients.
    Zobel G; Rödl S; Urlesberger B; Kuttnig-Haim M; Ring E
    Kidney Int Suppl; 1998 May; 66():S169-73. PubMed ID: 9573597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin supplementation for anticoagulation during continuous hemofiltration in critically ill patients with septic shock: a case-control study.
    du Cheyron D; Bouchet B; Bruel C; Daubin C; Ramakers M; Charbonneau P
    Crit Care; 2006; 10(2):R45. PubMed ID: 16542495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New modes of continuous renal replacement therapy using a refiltering technique to reduce micronutrient loss.
    Wu B; Ji D; Xu B; Fan R; Gong D
    Hemodial Int; 2019 Apr; 23(2):181-188. PubMed ID: 30740858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced hemolysis in pediatric patients requiring extracorporeal membrane oxygenation and continuous renal replacement therapy.
    Betrus C; Remenapp R; Charpie J; Kudelka T; Brophy P; Smoyer WE; Lin JJ
    Ann Thorac Cardiovasc Surg; 2007 Dec; 13(6):378-83. PubMed ID: 18292719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predilution versus postdilution during continuous venovenous hemofiltration: a comparison of circuit thrombogenesis.
    de Pont AC; Bouman CS; Bakhtiari K; Schaap MC; Nieuwland R; Sturk A; Hutten BA; de Jonge E; Vroom MB; Meijers JC; Büller HR
    ASAIO J; 2006; 52(4):416-22. PubMed ID: 16883122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Continuous blood purification therapy on 16 patients with diabetic ketoacidosis and acute kidney injury].
    Yue RZ; Zhang L; Liu F; Fu P
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 May; 43(3):434-7. PubMed ID: 22812253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of 2-hour creatinine clearance to guide cessation of continuous renal replacement therapy.
    Fröhlich S; Donnelly A; Solymos O; Conlon N
    J Crit Care; 2012 Dec; 27(6):744.e1-5. PubMed ID: 23102534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.